Biofrontera (BFRI) Consolidated Net Income (2020 - 2025)

Biofrontera's Consolidated Net Income history runs 6 years deep, the most recent figure standing at $5.6 million for Q4 2025.

• In Q4 2025, Consolidated Net Income rose 504.01% year-over-year to $5.6 million; the TTM figure through Dec 2025 stood at -$10.5 million (up 40.67% YoY), while the FY2025 annual figure was -$10.5 million, up 40.67% from the prior year.
• Consolidated Net Income was $5.6 million for Q4 2025 at Biofrontera, up from -$6.6 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $5.6 million in Q4 2025 to a low of -$16.0 million in Q3 2021.
• Historically, Consolidated Net Income has averaged -$4.3 million across 5 years, with a median of -$3.9 million in 2021.
• The sharpest annual moves came in 2021 and 2025: Consolidated Net Income tumbled 7698.39% in 2021, then jumped 504.01% in 2025.
• A 5-year view of Consolidated Net Income shows it stood at -$14.5 million in 2021, then soared by 80.8% to -$2.8 million in 2022, then jumped by 226.61% to $3.5 million in 2023, then slumped by 139.59% to -$1.4 million in 2024, then surged by 504.01% to $5.6 million in 2025.
• The last three Consolidated Net Income figures came in at $5.6 million (Q4 2025), -$6.6 million (Q3 2025), and -$5.3 million (Q2 2025), per Business Quant data.